Drugs Made In America Acquisition (DMAA) Stock Insights
$263.89M
Market Cap
—
P/E
—
Forward P/E
—
Score
DMAA price $10.87 +0.00 +0.00%
DMAA fair value $2.73. Price $10.87. Price is 298% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-02-18 | Drugs Made In America Acquisition LLC | Buy | 30.00K | — | — |
| 2025-02-18 | Drugs Made In America Acquisition LLC | Buy | 30.00K | — | — |
| 2025-02-18 | Stockwell Lynn | Buy | 30.00K | — | — |
| 2025-02-18 | Stockwell Lynn | Buy | 30.00K | — | — |
| 2025-01-29 | Drugs Made In America Acquisition LLC | Buy | 400.00K | — | — |
| 2025-01-29 | Drugs Made In America Acquisition LLC | Sell | 400.00K | — | — |
| 2025-01-29 | Drugs Made In America Acquisition LLC | Sell | 5.70M | $1.50 | 8.55M |
| 2025-01-29 | Drugs Made In America Acquisition LLC | Buy | 400.00K | — | — |
| 2025-01-29 | Stockwell Lynn | Sell | 400.00K | — | — |
| 2025-01-29 | Stockwell Lynn | Sell | 5.70M | $1.50 | 8.55M |
| 2025-01-29 | Stockwell Lynn | Buy | 400.00K | — | — |
| 2025-01-29 | Stockwell Lynn | Buy | 400.00K | — | — |
| 2025-01-29 | Shulgan Myron W. | Buy | 100.00K | — | — |
| 2025-01-29 | Prasad Sridhar G. | Buy | 100.00K | — | — |
| 2025-01-29 | Do Catherine | Buy | 100.00K | — | — |
| 2025-01-29 | Worman Glenn C. | Buy | 100.00K | — | — |
| 2025-01-07 | Do Catherine | Other | 0 | — | — |
| 2025-01-07 | Prasad Sridhar G. | Other | 0 | — | — |
| 2025-01-07 | Drugs Made In America Acquisition LLC | Other | 0 | — | — |
| 2025-01-07 | Stockwell Lynn | Other | 0 | — | — |
| 2025-01-07 | Shulgan Myron W. | Other | 0 | — | — |
| 2025-01-07 | Worman Glenn C. | Other | 0 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 23, holders -16 vs prior quarter. Ownership 59.54%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 2.51M | -22.70K | -0.90% | 26.71M |
| MIZUHO SECURITIES USA LLC | 2.07M | 69.61K | +3.48% | 21.93M |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 1.15M | -454.00K | -28.38% | 12.20M |
| GLAZER CAPITAL, LLC | 999.90K | -678.51K | -40.43% | 10.65M |
| WOLVERINE ASSET MANAGEMENT LLC | 832.09K | -721.62K | -46.44% | 8.86M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 809.05K | -514.30K | -38.86% | 8.62M |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 786.46K | -1.46M | -64.93% | 8.38M |
| HEIGHTS CAPITAL MANAGEMENT, INC | 648.08K | -1.92K | -0.29% | 6.90M |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 581.79K | -1.09M | -65.14% | 6.20M |
| ARISTEIA CAPITAL, L.L.C. | 350.00K | -531.72K | -60.30% | 3.73M |
| SONA ASSET MANAGEMENT (US) LLC | 162.79K | 0 | 0.00% | 1.73M |
| CLEAR STREET GROUP INC. | 382.44K | 28.39K | +8.02% | 1.65M |
| RLH CAPITAL LLC | 115.61K | -200.94K | -63.48% | 1.23M |
| LOGAN STONE CAPITAL, LLC | 109.96K | 109.96K | New | 1.17M |
| TORONTO DOMINION BANK | 100.00K | -103.84K | -50.94% | 1.06M |
| METEORA CAPITAL, LLC | 97.84K | -282.46K | -74.27% | 1.04M |
| QUARRY LP | 65.55K | -201.00K | -75.41% | 698.12K |
| GEODE CAPITAL MANAGEMENT, LLC | 62.27K | 0 | 0.00% | 663.21K |
| JPMORGAN CHASE & CO | 49.89K | 10 | +0.02% | 531.34K |
| DAKOTA WEALTH MANAGEMENT | 36.40K | 0 | 0.00% | 387.66K |
| LINEAGE POINT CAPITAL LP | 31.84K | 0 | 0.00% | 339.10K |
| HRT FINANCIAL LP | 18.48K | -9.00K | -32.76% | 196.00K |
| MORGAN STANLEY | 28 | -30 | -51.72% | 298 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0 | -297.83K | -100.00% | 0 |
| DLD ASSET MANAGEMENT, LP | 0 | -100.56K | -100.00% | 0 |
Insights · Dividends · Forecast · Financials · Learn
$263.89M
Market Cap
—
P/E
—
Forward P/E
—
Score